TraitMech

TraitMech › ECOLOGY

biosafety level 4

METPO:1001105 · CLASS · REVIEWED

A biosafety level that poses extreme risk of life-threatening disease through aerosol transmission with no available treatment.

BSL-4 extreme-hazard classification

DOI-backed graph linking extreme virulence, aerosol transmissibility, and absence of available treatments to BSL-4 classification.

BSL-4 extreme-hazard classification Interactive directed graph showing evidence-backed causal relationships for biosafety level 4.

Edge evidence

  • extreme pathogen hazard confers biosafety level 4 METPO:2007700

    Extreme pathogen hazard without available treatment yields BSL-4 classification.

    • DOI:10.1146/annurev.micro.62.081307.162938 virulence factors Supports extreme virulence with absent countermeasures as the basis of BSL-4 classification.
  • biosafety level 4 is a biosafety level rdfs:subClassOf

    BSL-4 is a member of the biosafety-level classification.

    • DOI:10.1146/annurev.micro.62.081307.162938 virulence factors Supports BSL-4 as a member of the biosafety-level classification.
  • life-threatening disease requires containment level biosafety level 4

    Organisms causing life-threatening disease in a healthy host require BSL-4 maximum containment.

    • DOI:10.1016/j.pathol.2020.09.006 "Organisms that cause life-threatening disease in a healthy host..."
    • DOI:10.3390/laboratories1030013 BSL-4 as the highest containment level for the most dangerous, life-threatening agents.
  • absence of effective prevention or treatment requires containment level biosafety level 4

    Absence of effective prevention or treatment for an agent mandates BSL-4 containment.

    • DOI:10.1016/j.pathol.2020.09.006 "effective prevention and/or treatment are not usually available"
    • DOI:10.3390/laboratories1030013 BSL-4 representing maximum containment for agents with severe risks and no available treatments.
  • high risk of aerosol-transmitted laboratory infection requires containment level biosafety level 4

    High risk of aerosol-transmitted laboratory infection is a defining BSL-4 criterion.

    • DOI:10.1016/j.pathol.2020.09.006 "pose a high risk of aerosol-transmitted laboratory infections with no vaccine or therapy"
  • biosafety level 4 necessitates use of positive-pressure air-supplied suit

    BSL-4 containment necessitates wearing a full-body positive-pressure air-supplied suit.

    • DOI:10.1016/j.pathol.2020.09.006 "wearing a full body, positive pressure, air supplied suit"
    • DOI:10.3390/laboratories1030013 Suit labs adopted positive pressure suits as a hallmark advanced containment strategy.
  • biosafety level 4 requires airlock

    BSL-4 facilities require airlocks as a maximum-containment engineering control.

    • DOI:10.3390/laboratories1030013 "requires airlocks, showers, and specialized waste disposal"
  • biosafety level 4 requires decontamination shower

    BSL-4 facilities require personnel decontamination showers.

    • DOI:10.3390/laboratories1030013 "requires airlocks, showers, and specialized waste disposal"
  • biosafety level 4 requires specialized waste disposal

    BSL-4 facilities require specialized waste disposal systems.

    • DOI:10.3390/laboratories1030013 "requires airlocks, showers, and specialized waste disposal"

Provenance

Source
METPO (2025-11-25)
Definition source
DOI:10.1146/annurev.micro.62.081307.162938

Parent traits (1)

Synonyms (1)

  • 4 RELATED_SYNONYM · metpo.owl

kg-microbe context

Matched 1 kg-microbe node via direct_metpo.

  • METPO:1001105 [-2.744, -3.128, -2.945, +1.660, …]

512-dim DeepWalkSkipGramEnsmallen embedding from kg-microbe (2026-04-25).

Nearest neighbors in embedding space

Top-8 cosine-similar METPO traits from the 2026-04-25 deepwalk (512-D).

Deep research

Generated by just research-trait; source: research/traits/ecology/biosafety_level_4-deep-research-falcon.md

Unreviewed literature output — not curated TraitMech content Ontology identifiers suggested below have not been resolved against their ontologies, and some are known to be wrong. Check any CURIE against the source before using it. 
# Research Report: Biosafety Level 4 (BSL-4) as a Microbial Trait—Causal Graph Research

## Scope Summary
Biosafety level 4 (BSL-4) is defined as the highest biological containment category for laboratories and agents that pose an extreme risk of life-threatening disease, typically transmitted via aerosols and lacking effective prophylaxis or treatment. BSL-4 is a laboratory containment/risk category rather than an intrinsic microbial physiological trait, distinguished operationally from BSL-3 (addresses serious/lethal inhalation threats with less complex barriers) by requiring entirely self-contained facilities, full body air-supplied suits, specialized air and waste management, and strict personnel controls. The designation is governed by international and national agencies (WHO, CDC, etc.) with updated 2024 WHO Biosafety Guidelines providing new standards for global oversight (gao2024frombiosafetyto pages 5-6, gao2024frombiosafetyto pages 10-12).

BSL-4 containment most frequently applies to certain filoviruses (e.g., Ebola, Marburg), arenaviruses (e.g., Lassa), and other exotic agents with extreme hazards as classified by risk group 4. Recent reforms emphasize the need for centralized biosafety oversight and harmonized policy frameworks worldwide.

## Candidate Graph Nodes by Type
- **Viral proteins:** Ebola VP35, VP24, GP1/GP2; Lassa virus NP, GPC, Z, L; Marburg virus homologs
- **Host factors:** Importin alpha (IMPA family), LAMP1 (host entry), alpha-dystroglycan (variable for LASV); transcription factor STAT1; innate immune receptors (RIG-I, PACT); MAPK pathway
- **Disease processes:** Type I interferon response inhibition, immune antagonism, endothelial dysfunction, cytokine induction, macrophage/dendritic activation, organ injury
- **Containment/governance/trait nodes:** BSL-4 trait (METPO:1001105), BSL-3 trait (METPO:1001104), global BSL-4 laboratory count and governance, surrogate BSL-2 systems

## Key Evidence-Backed Causal Edges
| Subject | Predicate | Object | Source (DOI/URL) | Key snippet | Node type(s) | Curation uncertainty |
|---|---|---|---|---|---|---|
| Biosafety level 4 (BSL-4) | is_defined_as | highest containment level for dangerous/life-threatening pathogens | https://doi.org/10.3390/laboratories1030013 | “BSL-4 is characterized… as the highest containment level for dangerous and life-threatening pathogens” (gao2024frombiosafetyto pages 5-6) | trait class; containment level | Low |
| Biosafety level 3 (BSL-3) | differs_from | BSL-4 by handling serious/lethal inhalation agents with less complex containment | https://doi.org/10.3390/laboratories1030013 | “BSL-3 addresses agents causing serious or lethal diseases via inhalation… while BSL-4 requires more complex self-contained facilities for maximum containment” (gao2024frombiosafetyto pages 5-6) | trait class; containment level | Low |
| Global BSL-4 governance | has_current_count | 51 operational BSL-4 laboratories globally | https://doi.org/10.3390/laboratories1030013 | “51 BSL-4 laboratories currently operational globally, with 18 additional facilities in planning or construction” (gao2024frombiosafetyto pages 10-12) | governance/statistic | Low |
| External biorisk assessment of BSL-4 laboratories | found | only 7 of 27 assessed labs met high standards | https://doi.org/10.3390/laboratories1030013 | “A 2023 King's College London report assessing 27 BSL-4 laboratories found only seven met high standards of biorisk management” (gao2024frombiosafetyto pages 10-12) | governance/statistic | Medium |
| WHO Laboratory Biosafety Guideline (2024) | supports | countries lacking biosafety frameworks and emphasizes national oversight committees | https://doi.org/10.3390/laboratories1030013 | “the 2024 WHO Laboratory Biosafety Guideline was released to support countries lacking biosafety frameworks… emphasizing national biosafety oversight committees” (gao2024frombiosafetyto pages 10-12) | governance/policy | Medium |
| Lassa virus | requires_handling_in | BSL-4 conditions | https://doi.org/10.1080/22221751.2024.2356149 | “Lassa virus (LASV), a risk-group 4 pathogen, must be handled in biosafety level-4 (BSL-4) conditions” (nunez2024treatmentofhighly pages 26-28) | agent; containment assignment | Low |
| Lassa virus research constraints | motivate_development_of | BSL-2 surrogate reverse genetics systems | https://doi.org/10.1080/22221751.2024.2356149 | “thereby limiting its research and antiviral development… the first to study the complete LASV life cycle under BSL-2 conditions” (nunez2024treatmentofhighly pages 26-28) | application/model system | Low |
| Ebola virus VP35 | inhibits | type I interferon production/induction | https://doi.org/10.1007/s40121-023-00913-y | “VP35 inhibits both the production of type I interferon (IFN)” (ndayambaje2024molecularcharacterizationof pages 4-6) | viral protein; host process | Medium |
| Ebola/filovirus VP35 | binds | dsRNA and blocks RIG-I/PACT-dependent IFN-I induction | https://doi.org/10.3390/cells13010071 | “the viral VP35 protein, which binds dsRNA… inhibit RIG-I activation, blocking IFNα/β induction” (vogel2023viraltargetingof pages 4-6) | viral protein; ligand; innate immune pathway | Low |
| Ebola virus VP24 | competes_for_binding_to | importin alpha (IMPA5/6/7) | https://doi.org/10.3390/cells13010071 | “VP24 competes for this interaction, preventing STAT1 nuclear accumulation… by competitive binding to importin-alpha (IMPA) proteins, specifically IMPA5, 6, and 7” (vogel2023viraltargetingof pages 4-6) | viral protein; host transport protein | Low |
| Ebola virus VP24 | prevents | STAT1 nuclear accumulation and ISG expression | https://doi.org/10.3390/cells13010071 | “preventing STAT1 nuclear accumulation and subsequent ISG expression” (vogel2023viraltargetingof pages 4-6) | viral protein; transcription factor; antiviral gene expression | Low |
| VP24-IMPA antagonism | is_conserved_in | Orthoebolavirus but not Marburg virus | https://doi.org/10.3390/cells13010071 | “VP24-IMPA interaction is conserved in Orthoebolavirus genus but not Marburg virus” (vogel2023viraltargetingof pages 4-6) | comparative mechanism; taxon scope | Medium |
| Ebola virus GP1 | binds_and_undergoes_conformational_change_to_enable | GP2-mediated membrane fusion | https://doi.org/10.1186/s43042-024-00600-8 | “GP1 binds to host cells and undergoes conformational change to expose GP2, enabling viral fusion with host cell membranes” (ndayambaje2024molecularcharacterizationof pages 4-6) | viral glycoprotein; entry/fusion process | Medium |
| Ebola virus shed glycoprotein (GP) | acts_as | antibody decoy/antigen sink | https://doi.org/10.1186/s43042-024-00600-8 | “The shed glycoprotein (GP) acts as an antigen sink/decoy that absorbs antibodies” (ndayambaje2024molecularcharacterizationof pages 4-6) | secreted viral protein; immune evasion | Medium |
| Ebola virus shed glycoprotein (GP) | stimulates | macrophages and dendritic cells causing cytokine production and vascular permeability | https://doi.org/10.1186/s43042-024-00600-8 | “stimulating macrophages and dendritic cells, resulting in large-scale cytokine production and heightened vascular permeability” (ndayambaje2024molecularcharacterizationof pages 4-6) | viral protein; immune cells; pathophysiology | Medium |
| Filovirus infection | causes | organ injury via inflammation and endothelial dysfunction | https://doi.org/10.1038/s41390-023-02873-y | “organ injury due to inflammation, endothelial dysfunction” (ndayambaje2024molecularcharacterizationof pages 4-6) | disease process; host pathology | High |
| LASV infection | can_use | LAMP1 for entry in a BSL-2 surrogate system | https://doi.org/10.1080/22221751.2024.2356149 | “membrane protein 1 (LAMP1), but not α-dystroglycan (α-DG)” (nunez2024treatmentofhighly pages 26-28) | viral entry; host receptor | Medium |
| Alpha-dystroglycan | is_dispensable_for | LASVmg infection in helper-cell BSL-2 system | https://doi.org/10.1080/22221751.2024.2356149 | “a previously reported cellular receptor α-dystroglycan is dispensable for LASVmg infection” (nunez2024treatmentofhighly pages 26-28) | host receptor; surrogate assay finding | High |
| Mammarenavirus NP | functions_as | interferon antagonist | https://doi.org/10.1080/17460441.2024.2340494 | “Like NP, Z is an interferon antagonist” (nunez2024treatmentofhighly pages 26-28) | viral protein; innate immune antagonism | Medium |
| Mammarenavirus Z | functions_as | interferon antagonist | https://doi.org/10.1080/17460441.2024.2340494 | “Like NP, Z is an interferon antagonist” (nunez2024treatmentofhighly pages 26-28) | viral matrix protein; innate immune antagonism | Medium |
| Mammarenavirus Z | mediates | virion budding | https://doi.org/10.1080/17460441.2024.2340494 | “Z-mediated virion budding” (nunez2024treatmentofhighly pages 26-28) | viral matrix protein; egress process | Medium |


*Table: This table summarizes candidate evidence-backed causal graph edges relevant to the biosafety level 4 trait, combining containment definitions and representative taxon-specific mechanisms from Ebola and Lassa virus literature. It is useful for deciding which edges are appropriate for TraitMech curation and which should remain flagged as taxon-specific or uncertain.*

## Curation Warnings
* Mechanistic nodes (e.g., VP35–IFN-I antagonism) are well-established for Ebola/filoviruses but taxon-specific. These should be carefully flagged as taxon- or assay-specific if used for general BSL-4 trait curation.
* Governance, containment, and agent assignment edges (e.g., BSL-4 is highest containment for RG4 agents, distinction from BSL-3, etc.) are robust and universal, suitable for the general trait class.
* Some model findings (e.g., alpha-dystroglycan dispensability for LASV infection in surrogate BSL-2 systems) must be considered with caution for universal applicability.

## Bibliography and URLs (DOI-first)
- Gao W et al. (2024) From Biosafety to National Security: The Evolution and Challenges of Biosafety Laboratories. Laboratories. https://doi.org/10.3390/laboratories1030013 (gao2024frombiosafetyto pages 5-6, gao2024frombiosafetyto pages 10-12)
- Nuñez IA et al. (2024) Treatment of highly virulent mammarenavirus infections—status quo and future directions. Expert Opin Drug Discov. https://doi.org/10.1080/17460441.2024.2340494 (nunez2024treatmentofhighly pages 26-28)
- Vogel OA et al. (2023) Viral targeting of importin alpha-mediated nuclear import to block innate immunity. Cells. https://doi.org/10.3390/cells13010071 (vogel2023viraltargetingof pages 4-6)
- Ndayambaje M et al. (2024) Molecular characterization of ebola virus, immune response, and therapeutic challenges: a narrative review. Egyptian Journal of Medical Human Genetics. https://doi.org/10.1186/s43042-024-00600-8 (ndayambaje2024molecularcharacterizationof pages 4-6, ndayambaje2024molecularcharacterizationof pages 14-15)

## Summary
Significant progress has occurred from 2023–2024 in clarifying BSL-4 as a laboratory/containment trait, standardizing governance, and detailing viral-host mechanisms for classically assigned BSL-4 agents. Curation for TraitMech must distinguish between universal containment features and taxon-specific molecular mechanisms. See the embedded table for detailed evidence and curation assessment.

References

1. (gao2024frombiosafetyto pages 5-6): Wanying Gao, Zongzhen Wu, Kunlan Zuo, Qiangyu Xiang, Lu Zhang, Xiaoya Chen, Feng Tan, and Huan Liu. From biosafety to national security: the evolution and challenges of biosafety laboratories. Laboratories, 1:158-173, Dec 2024. URL: https://doi.org/10.3390/laboratories1030013, doi:10.3390/laboratories1030013. This article has 11 citations.

2. (gao2024frombiosafetyto pages 10-12): Wanying Gao, Zongzhen Wu, Kunlan Zuo, Qiangyu Xiang, Lu Zhang, Xiaoya Chen, Feng Tan, and Huan Liu. From biosafety to national security: the evolution and challenges of biosafety laboratories. Laboratories, 1:158-173, Dec 2024. URL: https://doi.org/10.3390/laboratories1030013, doi:10.3390/laboratories1030013. This article has 11 citations.

Showing the first 60 of 68 lines of findings; the linked file also carries the run's front matter and the prompt it was given — read the full report.

Discussions and Knowledge Gaps (1)

Open questions attached to this trait. Seeded by just knowledge-gap-scan and curated; see the corpus-wide index.

Every BSL-4 control this record requires assumes terrestrial gravity and somewhere to put contaminated air, water and waste -- suit overpressure, airlocks, chemical showers, specialized waste disposal. Which still contain an agent in a closed-loop habitat that recycles all three?

KNOWLEDGE GAP OPEN kgscan-e770cf01677c · raised by claude · 2026-08-17

Attached to causal_graphs#positive_pressure_suit, causal_graphs#airlock, causal_graphs#decontamination_shower, causal_graphs#specialized_waste_disposal

Sample-return and crewed-habitat missions need containment for agents with no countermeasure, which is exactly what BSL-4 is for. But every control edge runs outward from bsl4_trait to a piece of equipment -- `requires` an airlock, a decontamination shower, specialized waste disposal; `necessitates use of` a positive pressure suit -- so the controls are named as hardware rather than as the physics they rely on, and it is the physics that does or does not transfer. Sedimentation-dependent controls behave differently in microgravity, and a shower and a waste stream that both feed a recycling loop are not disposal. As written the record cannot distinguish a control that survives the move from one that does not, because it never says what any of them do.

Proposed experiments

  • Control-by-control containment audit in a closed-loop analogue analogue-habitat tracer study with parabolic-flight aerosol runs Model systems: sealed closed-loop habitat analogue with recycled atmosphere, parabolic flight or drop-tower reduced-gravity segments, non-infectious spore and fluorescent-particle tracers Perturbations: suit breach at defined overpressure, airlock cycling with no atmospheric exhaust available, chemical shower under water-recovery constraints Readouts: tracer crossing the containment boundary per control, settling versus suspension time in reduced gravity, tracer persisting in the atmospheric recycling loop Decides it: which controls hold tracer escape at terrestrial levels once gravity and exhaust assumptions are removed Supports if: overpressure-based controls transfer intact -- they depend on pressure differential, not on settling or exhaust Refutes if: escape rises for controls that passed on the ground -- the BSL-4 set does not transfer and needs habitat-specific equivalents
Provenance

Scan provenance (#409). The kg-microbe-kgscan pass raised this discussion with the prompt 'Knowledge gap for biosafety level 4: Finally, this review examines the largely unknown microbiology and infection implications of celestial body habitation with an emphasis placed on Mars.', whose sentence came from PMID:37362850. That sentence is about microbiology and infection during celestial body habitation, not about this trait: the scan matched the hedging vocabulary of a gap statement without checking that the gap was about the trait it was filed under. The prompt above was authored instead from this record's own causal graph, and none of these references are carried as its evidence, because they support the scraped sentence rather than the question. The scan attached 3 further references whose snippets concern neither that sentence nor this trait; all 4 are reproduced here so nothing it produced is lost: PMID:37362850 'Finally, this review examines the largely unknown microbiology and infection implications of celestial body habitation with an emphasis placed on Mars.'; PMID:41914886 'Both Old World arenaviruses LASV and LCMV exploit host tyrosine kinase signaling to establish infection, though the molecular mechanisms remain incompletely understood.'; PMID:40044492 'However, the comparatively low scientific commitment of countries that are usually among the major players in global scientific publications and the declining scientific interest in NiV research combined with the prevailing knowledge gaps in NiV infectiology in conjunction with the risk of NiV spreading to other areas is extremely threatening.'; PMID:39682751 'The COVID-19 pandemic has underscored the limitations of focusing solely on the pathogen-killing strategies of immunology and microbiology to address complex, multisystemic infectious diseases.'.

Curation history

  1. · SEEDED_FROM_METPO · seed_from_metpo

    imported from data/raw/metpo.owl (CLASS)

  2. · CURATED_CAUSAL_GRAPH · claude

    Added DOI-backed causal graph linking extreme pathogen hazard to BSL-4 classification.

  3. · GROUND_CAUSAL_PREDICATES · claude

    Grounded 2 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (METPO:2000202×1, rdfs:subClassOf×1).

  4. · ENRICH_CAUSAL_GRAPH · claude

    Added 7 evidence-backed generic edges (7 new nodes) from the deep-research report.

  5. · MIGRATE_MICROBE_DOMAIN_EDGES · claude

    Re-grounded 1 causal edge(s) off microbe-domain METPO predicates (1 to confers), issue 301. The previous predicates are transitively rdfs:subPropertyOf METPO:2000001, whose rdfs:domain is METPO:1000525 (microbe), so a causal-graph subject entailed that the subject IS a microbe; CausalNodeTypeEnum has no organism member, so no such edge could ever satisfy the domain. Edge directions are unchanged - this pass only relabels and re-grounds. RO:0002234 (has output) is used where the subject is an activity, since biolink gives it the domain 'biological process or activity'; the METPO replacements are proposed in proposals/metpo_traitmech_v8 and v9 and are placeholder ids until METPO mints them.

  6. · CURATE_KNOWLEDGE_GAPS · claude

    Replaced the scan's off-topic scraped sentence with a research question authored from this record's causal graph, anchored it via attaches_to, and sketched an experiment with a decision criterion. The scan's sentence and PMIDs are preserved in the discussion's notes.